医薬品輸送サービスの市場規模、シェア、動向分析レポート：タイプ別、サービス別、サプライチェーン別、地域別、セグメント予測、2025年～2030年

医薬品輸送サービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の医薬品輸送サービス市場規模は、2025年から2030年にかけてCAGR 7.71％を記録し、2030年には1,248億1,000万米ドルに達する見込みです。

同市場の成長は主に、温度変化に敏感な医薬品の需要増加、医薬品サプライチェーンの拡大、厳格なガイドラインの実施によるものです。

生物製剤、ワクチン、細胞・遺伝子治療の利用拡大が医薬品輸送サービス市場にプラスの影響を与えています。従来の低分子医薬品とは異なり、生物製剤は温度変化や物理的な取り扱いに非常に敏感であるため、製品の完全性を維持するために厳格なコールドチェーン物流が必要となります。この需要により、専用の冷蔵車両、冷蔵倉庫、および出荷プロセスを通じて中断のない温度管理を保証する包装ソリューションが普及しています。COVID-19ワクチンの流通を含む大規模なワクチン接種プログラムの展開は、温度管理された輸送の重要性を実証し、コールドチェーンインフラへの投資を加速させました。

さらに、製薬会社は製造・流通業務を開発・製造受託機関（CDMO）やロジスティクス・パートナーにアウトソーシングする傾向が強まっており、世界・サプライチェーンはさらに拡大しています。このような複雑なネットワークは地域をまたぐため、国際的な規制基準と現地の規制基準の両方を満たす、信頼性が高く、安全で、タイムリーな輸送サービスの必要性が生じています。医薬品のコンポーネントは、ある国で生産され、別の国で組み立てられ、複数の市場に流通する可能性があるため、同期化されたロジスティクス計画が必要となります。生産が分散化するにつれ、通関、書類作成、複合一貫輸送に精通したサードパーティロジスティクスプロバイダー（3PL）への依存度が高まっています。さらに、アジア太平洋、ラテンアメリカ、東欧の新興市場が製造と消費の両面で重要な拠点となり、医薬品の国際輸送の頻度と量が増加しています。

さらに、DHL、UPSヘルスケア、フェデックスエクスプレス、Kuehne+Nagelなど、同市場の主要な競合企業数社は、市場シェアを拡大するため、戦略的投資、提携、技術導入を通じて積極的に機能を拡充しています。コールドチェーンロジスティクスに対する需要の高まりを受けて、これらの企業はインフラやサービス提供の強化に取り組んでいます。例えば、2025年4月、DHLは「戦略2030」に沿ってライフサイエンスとヘルスケアのロジスティクスを強化するため、ヘルスロジスティクスに22億7,000万米ドルを投資しました。投資の半分は米国を対象としており、その他はアジア太平洋地域とEMEAに分かれ、世界なインフラを拡大しています。この動きは、患者に焦点を当てた統合的な医薬品輸送ソリューションを提供する上で、DHLの重要な競争相手としての役割を強化するものです。

医薬品輸送サービス市場のレポートハイライト

• タイプ別では、バイオ医薬品セグメントが2024年の市場を独占しました。このセグメントの成長は、生物製剤、遺伝子治療薬、個別化された医薬品を取り扱うことができる、効率的で安全かつコンプライアンスに準拠した輸送ソリューションに対する需要の高まりによるところが大きいです。
• サービス別では、航空貨物分野が2024年の市場を独占しました。このセグメントの成長は、高価値で時間的制約があり、温度管理された医薬品の迅速な配送に対する需要の増加に大きく起因しています。
• サプライチェーン別では、非コールドチェーンロジスティクス部門が2024年の市場を独占しました。このセグメントの成長は、医療機器、一般用医薬品（OTC）、一般医薬品流通に対する需要の高まりによるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医薬品輸送サービス市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し。
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• テクノロジー情勢
• 価格モデル分析
• 業界市場分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 医薬品輸送サービス市場：タイプ別推定・動向分析

• セグメントダッシュボード
• 世界の医薬品輸送サービス市場のタイプ別変動分析
• 世界の医薬品輸送サービス市場規模と動向分析（タイプ別、2018～2030年）
• バイオ医薬品
  • ワクチン
  • バイオシミラー
  • 血漿由来製品
  • その他
• 医薬品

第5章 医薬品輸送サービス市場：サービス別推定・動向分析

• セグメントダッシュボード
• 世界の医薬品輸送サービス市場のサービス別変動分析
• 世界の医薬品輸送サービス市場規模と動向分析（サービス別、2018～2030年）
• 航空貨物
• 海上貨物
• 陸路

第6章 医薬品輸送サービス市場：サプライチェーン別推定・動向分析

• セグメントダッシュボード
• 世界の医薬品輸送サービス市場のサプライチェーン別変動分析
• 世界の医薬品輸送サービス市場規模と動向分析（サプライチェーン別、2018～2030年）
• コールドチェーン物流
• 非コールドチェーン物流

第7章 医薬品輸送サービス市場：地域別推定・動向分析

• 地域別市場シェア分析、2024年・2030年
• 地域別市場ダッシュボード
• 市場規模と予測動向分析、2018年～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • ノルウェー
  • スウェーデン
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 競合の分類
• 企業市場シェア/評価分析、2024年
• 企業プロファイル
  • CEVA Logistics
  • Cencora Corporation（ICS）
  • DB SCHENKER
  • Kuehne+Nagel
  • Kerry Logistics Network Limited
  • Cardinal Health
  • FedEx
  • McKesson Corporation
  • DHL
  • EVERSANA
  • Thermo Fisher Scientific
  • Knipper Health

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 4 Global pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 5 Global pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 6 Global pharmaceutical transportation services Market, by Region, 2018 - 2030 (USD Million)
• Table 7 North America pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 8 North America pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 9 North America pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 10 U.S. pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 11 U.S. pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 12 U.S. pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 13 Canada pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 14 Canada pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 15 Canada pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 16 Mexico pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 17 Mexico pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 18 Mexico pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 19 Europe pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
• Table 20 Europe pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 21 Europe pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 22 Europe pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 23 Germany pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 24 Germany pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 25 Germany pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 26 UK pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 27 UK pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 28 UK pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 29 France pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 30 France pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 31 France pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 32 Italy pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 33 Italy pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 34 Italy pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 35 Spain pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 36 Spain pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 37 Spain pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 38 Denmark pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 39 Denmark pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 40 Denmark pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 41 Norway pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 42 Norway pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 43 Norway pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 44 Sweden pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 45 Sweden pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 46 Sweden pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 51 China pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 52 China pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 53 China pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 54 Japan pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 55 Japan pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 56 Japan pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 57 India pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 58 India pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 59 India pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 60 South Korea pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 61 South Korea pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 62 South Korea pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 63 Australia pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 64 Australia pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 65 Australia pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 66 Thailand pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 67 Thailand pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 68 Thailand pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 69 Latin America pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
• Table 70 Latin America pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 71 Latin America pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 72 Latin America pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 73 Brazil pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 74 Brazil pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 75 Brazil pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 76 Argentina pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 77 Argentina pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 78 Argentina pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 83 South Africa pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 84 South Africa pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 85 South Africa pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 89 UAE pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 90 UAE pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 91 UAE pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
• Table 92 Kuwait pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
• Table 93 Kuwait pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
• Table 94 Kuwait pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Pharmaceutical Transportation Services Market Segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segment snapshot 1
• Fig. 14 Segment snapshot 2
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Market trends & outlook
• Fig. 17 Porter's five force analysis
• Fig. 18 PESTEL by SWOT analysis
• Fig. 19 Pharmaceutical transportation services market: Type outlook key takeaways
• Fig. 20 Pharmaceutical transportation services market: Type movement analysis
• Fig. 21 Biopharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Plasma Derived Products market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Pharmaceutical Transportation Services Market: Services outlook key takeaways
• Fig. 28 Pharmaceutical Transportation Services Market: Services movement analysis
• Fig. 29 Cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Non-cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Regional marketplace outlook, 2024 & 2030 (USD Million)
• Fig. 32 Regional marketplace: Key takeaways
• Fig. 33 North America pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Key country dynamics
• Fig. 35 U.S. pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Key country dynamics
• Fig. 37 Canada pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Key country dynamics
• Fig. 39 Mexico pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Key country dynamics
• Fig. 41 Europe pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Key country dynamics
• Fig. 43 UK regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Key country dynamics
• Fig. 45 Germany pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 France pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 Italy pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Spain pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 Denmark pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 Norway pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 Sweden pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Asia Pacific pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 Japan pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 China pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 India pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 Australia pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 South Korea pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 Thailand pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Latin America pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Key country dynamics
• Fig. 73 Brazil pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 Argentina pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 MEA pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 South Africa pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 Saudi Arabia pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 UAE pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 Kuwait regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Market participant categorization
• Fig. 87 Precision medicine market share/assessment analysis, 2024
• Fig. 88 Strategic framework

Pharmaceutical Transportation Services Market Growth & Trends:

The global pharmaceutical transportation services market size is expected to reach USD 124.81 billion by 2030, registering a CAGR of 7.71% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is mainly due to increasing demand for temperature sensitive drugs, expansion of pharmaceutical supply chain, and implementation of stringent guideline.

The growing use of biologics, vaccines, and cell and gene therapies has positively impacted the pharmaceutical transportation services market. Unlike conventional small-molecule drugs, biologics are highly sensitive to temperature variations and physical handling, requiring strict cold chain logistics to maintain product integrity. This demand has led to the proliferation of specialized refrigerated vehicles, cold storage warehouses, and packaging solutions that ensure uninterrupted temperature control throughout the shipping process. The rollout of large-scale vaccination programs, including COVID-19 vaccine distribution, demonstrated the critical importance of temperature-controlled transport and accelerated investment in cold chain infrastructure.

Furthermore, the pharmaceutical companies are increasingly outsourcing manufacturing and distribution activities to contract development and manufacturing organizations (CDMOs) and contract logistics partners, further expanding global supply chains. These complex networks span across regions, creating a need for reliable, secure, and timely transportation services that meet both international and local regulatory standards. Drug components may be produced in one country, assembled in another, and distributed across multiple markets, necessitating synchronized logistics planning. As production decentralizes, the reliance on third-party logistics providers (3PLs) with expertise in navigating customs, documentation, and multi-modal transport has increased. Furthermore, emerging markets in Asia-Pacific, Latin America, and Eastern Europe have become important hubs for both manufacturing and consumption, increasing the frequency and volume of international pharmaceutical shipments.

Furthermore, several key competitors in the market, such as DHL, UPS Healthcare, FedEx Express, and Kuehne+Nagel, are actively expanding capabilities through strategic investments, partnerships, and technology adoption to gain market share. The rising demand for cold chain logistics has led these players to enhance their infrastructure and service offerings. For instance, in April 2025, DHL invested USD 2.27 billion in health logistics to strengthen its life sciences and healthcare logistics, aligning with its "Strategy 2030." Half of the investment targets the U.S., with the rest split between Asia Pacific and EMEA, expanding global infrastructure. This move reinforces DHL's role as a key competitor in providing integrated, patient-focused pharmaceutical transportation solutions.

Pharmaceutical Transportation Services Market Report Highlights:

• Based on type, the biopharmaceuticals segment dominated the market in 2024. The growth of this segment is largely attributed to the rising demand for efficient, secure, and compliant transportation solutions capable of handling biologics, gene therapies, and personalized medications.
• Based on the services, the air freight segment dominated the market in 2024. The growth of this segment is largely attributed to the increasing demand for rapid delivery of high-value, time-sensitive, and temperature-controlled pharmaceutical products.
• Based on the supply chain, the non-cold chain logistics segment dominated the market in 2024. The segment's growth is due to the rising demand for medical devices, over the counter (OTC) drugs, and general pharmaceutical distribution.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Information Analysis
  • 1.4.2. Market Formulation & Data Visualization
  • 1.4.3. Data Validation & Publishing
• 1.5. Model Details
  • 1.5.1. Commodity Flow Analysis (Model 1)
  • 1.5.2. Top Down Market Estimation (Model 2)
  • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
  • 1.5.4. Multivariate Analysis (Model 4)
• 1.6. List of Secondary Sources
• 1.7. List of Abbreviations
• 1.8. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Pharmaceutical Transportation Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Demand for Biopharmaceuticals and Specialty Drugs
    • 3.2.1.2. Expansion of Global Pharmaceutical Supply Chain
    • 3.2.1.3. Stringent Regulatory Requirements and Quality Assurance Standards
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Cold Chain Infrastructure and Maintenance
    • 3.2.2.2. Complex Regulatory and Customs Compliance Across Regions
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. Industry Market Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. PESTEL Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Transportation Services Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Pharmaceutical Transportation Services Market Type Movement Analysis
• 4.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Biopharmaceuticals
  • 4.4.1. Biopharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Vaccines
    • 4.4.2.1. Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Biosimilars
    • 4.4.3.1. Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Plasma Derived Products
    • 4.4.4.1. Plasma Derived Products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Pharmaceuticals
  • 4.5.1. Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Transportation Services Market: Services Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Pharmaceutical Transportation Services Market Services Movement Analysis
• 5.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)
• 5.4. Air Freight
  • 5.4.1. Air Freight market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Sea Freight
  • 5.5.1. Sea Freight market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Overland
  • 5.6.1. Overland market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Transportation Services Market: Supply Chain Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Pharmaceutical Transportation Services Market Supply Chain Movement Analysis
• 6.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Supply Chain, 2018 to 2030 (USD Million)
• 6.4. Cold Chain Logistics
  • 6.4.1. Cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Non-cold Chain Logistics
  • 6.5.1. Non-cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pharmaceutical Transportation Services Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030 (USD Million)
• 7.4. North America
  • 7.4.1. North America Market Estimates and Forecasts 2018 to 2030, (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory scenario
    • 7.4.2.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory scenario
    • 7.4.3.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory scenario
    • 7.4.4.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory scenario
    • 7.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory scenario
    • 7.5.3.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory scenario
    • 7.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory scenario
    • 7.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory scenario
    • 7.5.6.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory scenario
    • 7.5.7.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Norway
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Competitive scenario
    • 7.5.8.3. Regulatory scenario
    • 7.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key country dynamics
    • 7.5.9.2. Competitive scenario
    • 7.5.9.3. Regulatory scenario
    • 7.5.9.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory scenario
    • 7.6.2.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory scenario
    • 7.6.3.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory scenario
    • 7.6.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory scenario
    • 7.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory scenario
    • 7.6.6.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory scenario
    • 7.6.7.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory scenario
    • 7.7.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory scenario
    • 7.7.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory scenario
    • 7.8.2.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory scenario
    • 7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive scenario
    • 7.8.4.3. Regulatory scenario
    • 7.8.4.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive scenario
    • 7.8.5.3. Regulatory scenario
    • 7.8.5.4. Israel market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Competition Categorization
• 8.2. Company Market Share/Assessment Analysis, 2024
• 8.3. Company Profiles
  • 8.3.1. CEVA Logistics
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Service benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Cencora Corporation (ICS)
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Service benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. DB SCHENKER
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Service benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Kuehne+Nagel
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Service benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Kerry Logistics Network Limited
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Service benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Cardinal Health
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Service benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. FedEx
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Service benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. McKesson Corporation
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Service benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. DHL
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Service benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. EVERSANA
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Service benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Thermo Fisher Scientific
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Service benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Knipper Health
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Service benchmarking
    • 8.3.12.4. Strategic initiatives